Epidiolex (prescription cannabidiol) Utilization Patterns: A Query Builder Analysis

    Basic Details
    Date Posted
    Monday, March 28, 2022
    Status
    Complete
    Medical Product
    Epidiolex (prescription cannabidiol)
    Description

    This request assessed utilization patterns for Epidiolex (prescription cannabidiol). This assessment was part of FDA's mission to perform surveillance of cannabidiol-containing products.

    The study period includes data from July 1, 2018 to March 31, 2020. This analysis includes two reports:

    • Report 1: We executed this request on IBM® MarketScan® Research Databases on July 22, 2021. This report specifies age groupings of 0-5, 6-10, 11-17, and 18+ years.
    • Report 2: We executed this request on IBM® MarketScan® Research Databases on July 22, 2021. This report specifies age groupings of 0-17 and 18+ years.
    Additional Details
    FDA Center
    CDER
    Time Period
    July 1, 2018 – March 31, 2020
    Study Type
    Query Builder
    Assessment Type
    Exploratory Analyses
    Population / Cohort
    All individuals
    Data Sources
    IBM® MarketScan® Research Databases